Provision Language
Patent Expenses: Exclusive Licensees will reimburse NIH for up to 50% of patent expenses and annuities for licensed territories incurred after the Effective Date of the Exclusive Commercialization License depending on the potential market and scope of license. Non–exclusive licensees of a patent or patent family will divide equally the reimbursement to NIH for up to 50% of patent expenses and annuities for licensed territories incurred after the Effective Date of the Non–Exclusive Commercialization License depending on the potential market and scope of license.